SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer Growth.
Details
Serval ID
serval:BIB_8768846D2B6D
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer Growth.
Journal
Cancer Research
ISSN
1538-7445 (Electronic)
ISSN-L
0008-5472
Publication state
Published
Issued date
2013
Peer-reviewed
Oui
Volume
73
Number
12
Pages
3578-3590
Language
english
Abstract
Activation of the transcription factor PPARγ by the n-3 fatty acid docosahexaenoic acid (DHA) is implicated in controlling proinflammatory cytokine secretion, but the intracellular signaling pathways engaged by PPARγ are incompletely characterized. Here, we identify the adapter-encoding gene SOCS3 as a critical transcriptional target of PPARγ. SOCS3 promoter binding and gene transactivation by PPARγ was associated with a repression in differentiation of proinflammatory T-helper (TH)17 cells. Accordingly, TH17 cells induced in vitro displayed increased SOCS3 expression and diminished capacity to produce interleukin (IL)-17 following activation of PPARγ by DHA. Furthermore, naïve CD4 T cells derived from mice fed a DHA-enriched diet displayed less capability to differentiate into TH17 cells. In two different mouse models of cancer, DHA prevented tumor outgrowth and angiogenesis in an IL-17-dependent manner. Altogether, our results uncover a novel molecular pathway by which PPARγ-induced SOCS3 expression prevents IL-17-mediated cancer growth. Cancer Res; 73(12); 3578-90. ©2013 AACR.
Pubmed
Web of science
Open Access
Yes
Create date
18/07/2013 7:30
Last modification date
18/02/2020 6:20